Home > Financial Ratios > DIVIS LABORATORIES

DIVIS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

DIVIS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 30.49-6.23-32.1036.7145.25

What is the latest Core EBITDA Growth ratio of DIVIS LABORATORIES ?

The latest Core EBITDA Growth ratio of DIVIS LABORATORIES is 30.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202530.49
Mar2024-6.23
Mar2023-32.10
Mar202236.71
Mar202145.25

How is Core EBITDA Growth of DIVIS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 30.49
Positive
Mar2024 -6.23
Negative
Mar2023 -32.1
Negative
Mar2022 36.71
-18.87
Mar2021 45.25 -

Other Financial Ratios of DIVIS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹171,898.0 Cr 5.5% -0.2% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics
MANKIND PHARMA ₹86,144.2 Cr 0.2% -6.3% -16.6% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

5.5%

-0.2%

0.8%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses